Marc Blouin

Author PubWeight™ 6.61^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors: structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinity.	J Med Chem	2003	1.03
2	Discovery of L-791,943: a potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor.	Bioorg Med Chem Lett	2002	0.82
3	Substituted 4-(2,2-diphenylethyl)pyridine-N-oxides as phosphodiesterase-4 inhibitors: SAR study directed toward the improvement of pharmacokinetic parameters.	Bioorg Med Chem Lett	2002	0.81
4	2,3-Diarylthiophenes as selective EP1 receptor antagonists.	Bioorg Med Chem Lett	2005	0.81
5	Improving metabolic stability of phosphodiesterase-4 inhibitors containing a substituted catechol: prevention of reactive intermediate formation and covalent binding.	Bioorg Med Chem Lett	2002	0.81
6	Substituted 2-pyridinemethanol derivatives as potent and selective phosphodiesterase-4 inhibitors.	Bioorg Med Chem Lett	2003	0.78
7	Substituted aminopyridines as potent and selective phosphodiesterase-4 inhibitors.	Bioorg Med Chem Lett	2003	0.77
8	Lack of clinical efficacy of a phosphodiesterase-4 inhibitor for treatment of heaves in horses.	J Vet Intern Med	2006	0.76